Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
05 2019
Historique:
received: 20 12 2018
accepted: 13 02 2019
pubmed: 21 2 2019
medline: 31 3 2020
entrez: 21 2 2019
Statut: epublish

Résumé

Critically ill patients are frequently treated with empirical antibiotic therapy, including vancomycin and β-lactams. Recent evidence suggests an increased risk of acute kidney injury (AKI) in patients who received a combination of vancomycin and piperacillin-tazobactam (VPT) compared with patients who received vancomycin alone or vancomycin in combination with cefepime (VC) or meropenem (VM), but most studies were conducted predominately in the non-critically ill population. A retrospective cohort study that included 2,492 patients was conducted in the intensive care units of a large university hospital with the primary outcome being the development of any AKI. The rates of any AKI, as defined by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, were 39.3% for VPT patients, 24.2% for VC patients, and 23.5% for VM patients (

Identifiants

pubmed: 30782987
pii: AAC.02658-18
doi: 10.1128/AAC.02658-18
pmc: PMC6496064
pii:
doi:

Substances chimiques

Vancomycin 6Q205EH1VU
Cefepime 807PW4VQE3
Meropenem FV9J3JU8B1
Tazobactam SE10G96M8W
Piperacillin X00B0D5O0E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Ann Pharmacother. 2018 Jul;52(7):639-644
pubmed: 29442542
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
Crit Care. 2016 Jun 04;20(1):159
pubmed: 27388905
Surg Infect (Larchmt). 2016 Feb;17(1):38-47
pubmed: 26484854
Pharmacotherapy. 2014 Jul;34(7):670-6
pubmed: 24855041
Clin Infect Dis. 2017 Nov 29;65(12):2137-2143
pubmed: 29020249
Ann Intern Med. 2016 Oct 4;165(7):473-481
pubmed: 27479614
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Crit Care. 2015 Nov 03;19:383
pubmed: 26526622
Antimicrob Agents Chemother. 2013 Feb;57(2):734-44
pubmed: 23165462
J Am Soc Nephrol. 2005 Nov;16(11):3365-70
pubmed: 16177006
Pharmacotherapy. 2016 May;36(5):463-71
pubmed: 26952639
Clin Ther. 2016 Mar;38(3):494-502
pubmed: 26831569
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98
pubmed: 19106348
Ann Intensive Care. 2017 Dec;7(1):49
pubmed: 28474317
Clin Infect Dis. 2017 Jan 15;64(2):116-123
pubmed: 27986669
Ann Pharmacother. 2015 Oct;49(10):1113-9
pubmed: 26160972
Pharmacotherapy. 1997 Jan-Feb;17(1):166-9
pubmed: 9017778
Crit Care Med. 2018 Jan;46(1):12-20
pubmed: 29088001
Crit Care Med. 2009 Mar;37(3):819-24
pubmed: 19237883
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
BMJ Open. 2012 Mar 11;2(2):e000635
pubmed: 22411933
BMC Res Notes. 2015 Oct 17;8:579
pubmed: 26476979
Am J Nephrol. 2012;35(4):349-55
pubmed: 22473149
BMC Nephrol. 2017 Feb 20;18(1):70
pubmed: 28219327
Pharmacotherapy. 2014 Jul;34(7):662-9
pubmed: 24753221
Clin Infect Dis. 2019 Apr 24;68(9):1456-1462
pubmed: 30165426
Pharmacotherapy. 2016 Dec;36(12):1217-1228
pubmed: 27805728
J Crit Care. 2018 Dec;48:32-38
pubmed: 30172962
Pharmacotherapy. 2014 Jul;34(7):653-61
pubmed: 24700598
Clin Infect Dis. 2016 Dec 10;64(5):666-674
pubmed: 27940946
J Am Soc Nephrol. 2017 Jun;28(6):1723-1728
pubmed: 28082518
Ther Adv Endocrinol Metab. 2016 Jun;7(3):136-47
pubmed: 27293542
Crit Care Med. 2015 Aug;43(8):e269-75
pubmed: 25962084
Antimicrob Agents Chemother. 2015 Sep;59(9):5470-4
pubmed: 26124161
J Pharm Pract. 2017 Apr;30(2):209-213
pubmed: 26912532
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29712661
J Antimicrob Chemother. 1994 Oct;34(4):555-64
pubmed: 7868407
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):187-96
pubmed: 25424992
Clin Microbiol Infect. 2014 Jun;20(6):O384-9
pubmed: 24118354
J Pediatr Pharmacol Ther. 2016 Jul-Aug;21(4):332-338
pubmed: 27713673

Auteurs

Adam M Blevins (AM)

Department of Pharmacy, The University of Kansas Health System, Kansas City, Kansas, USA.

Jennifer N Lashinsky (JN)

Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA.

Craig McCammon (C)

Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA.

Marin Kollef (M)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Scott Micek (S)

Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA.
Department of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, Missouri, USA.

Paul Juang (P)

Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA Paul.Juang@stlcop.edu.
Department of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH